Email - RxTalks Banner – Date-Location (3)

Amgen discovers, develops, manufactures, and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science’s promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people’s lives. For more information, visit and follow us on twitter @AmgenCanadaGM and on Facebook @AmgenCanada

Kimberly Schroeder

[email protected]


6775 Financial Drive, Suite 100
Mississauga, ON L5N 0A4

Dexcom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) systems. Founded in 1999 and headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom strives to simplify and improve diabetes management around the world.

CGM systems are medical devices that can show patients’ glucose levels (including the rate of change and direction) throughout the day and night. Dexcom CGM reduces some of the guesswork that comes with making diabetes treatment decisions, offering our users’ greater peace of mind.

Sabrina Chiatto

[email protected]

[email protected]


embecta, formerly part of BD (Becton, Dickinson and Company), is one of the largest pure-play diabetes care companies in the world, leveraging its nearly 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of more than 2,000 employees around the globe. For more information, visit

Robin Meyer

[email protected]

416.540.8313 “7025

Langer Drive, Suite 100
Mississauga, Ontario L5N 0E8″

Coming Soon.

The future is bright We are committed to supporting pharmacists, so they can focus on what’s most important, that is, the well-being of Canadians. Through continued access to our highly diversified portfolio, our vision is to become the largest Canadian pharmaceutical company dedicated to creating a brighter, healthier future for all. Let’s work together, now more than ever, to make a positive change.

Garrett Rocca

Director of Sales

[email protected]


Coming Soon.

Robin Yuen

Team Lead, Ontario Pharmacy Health Program

[email protected]


Ontario Pharmacy Health Program;  Service Provider Lifemark Health Corp.  243 Consumers Rd.  12th Floor, Toronto, ON  M2J 4W8

Coming Soon.

Migraine Canada (MC) is a national registered charity dedicated to improving the lives of Canadians living with migraine and other headache conditions. It is estimated that 12% or 4.5 million Canadians live with migraine. Migraine does not discriminate. This devastating disease affects children, women and men of all races.

Our role is to provide credible information, resources and programs to support the community including patients, loved ones and the healthcare professionals who treat them. We advocate on their behalf for access to treatment and care and health outcomes are optimized.

Wendy Gerhart

Executive Director

[email protected]


20 Loftus Road
Phelpston, Ontario L0L 2K0

Jack Fava, BSc.(H)

Senior Product Manager, Marketing

[email protected]

Floree Thistle, B.Sc.Phm., MBA

Senior Product Manager, Marketing

[email protected]

Valneva is a specialty vaccine company focused on prevention of infectious diseases with significant unmet medical need. Our vision is to contribute to a world in which no one dies or suffers from a vaccine-preventable disease. Valneva’s portfolio includes three commercial vaccines for travellers: IXIARO® (Japanese encephalitis vaccine, inactivated, adsorbed); DUKORAL® (oral, inactivated cholera and Enterotoxigenic E. Coli (ETEC) Diarrhea Vaccine); and RabAvert® (rabies vaccine). Valneva also distributes and commercializes KamRAB®, a human rabies immunoglobulin. Our R&D pipeline includes vaccine candidates against Lyme disease and Chikungunya.

Coming Soon.

Sanjay Chopra

[email protected]

416-433-8242 ext. 145

Royal Crest Ct #10, Markham, ON L3R 9Z4

For sponsorship opportunities or exhibitor inquiry, please contact [email protected]

View RxTalks 2023 Prospectus

Friday, July 21, 2023

Friday, September 8, 2023

Graphics - People 2.2